Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)

Subscribe to Selected New Research on Pregnancy-Induced Hypertension

1343 relevant articles (36 outcomes, 234 trials/studies) found for this Disease

Description: A condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.

Also Known As:

Hypertension, Pregnancy Induced; Hypertension, Pregnancy-Induced; Gestational Hypertension; Transient Hypertension, Pregnancy; Hypertension, Gestational; Hypertension, Pregnancy Transient; Pregnancy Transient Hypertension

Relationship Network

Disease Context: Research Results

Female Urogenital Diseases and Pregnancy Complications

Pregnancy Complications: 552

Pregnancy-Induced Hypertension: 1343

Pre-Eclampsia: 6795

Eclampsia: 1097

HELLP Syndrome: 696

Cardiovascular Diseases: 20552

Vascular Diseases: 7633

Hypertension: 76484

Pregnancy-Induced Hypertension: 1343

Related Diseases

1.	Pre-Eclampsia (Preeclampsia)
2.	Hypertension (High Blood Pressure)
3.	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
4.	Fetal Growth Retardation (Intrauterine Growth Retardation)
5.	Fetal Death

Experts

1.	Xiang, Wenpei: 3 articles (01/2006 - 01/2003)
2.	Chen, Hanping: 3 articles (01/2006 - 01/2003)
3.	Wang, C: 3 articles (04/2001 - 01/2001)
4.	Chen, J: 3 articles (04/2001 - 02/2000)
5.	Grignon, A: 2 articles (08/2008 - 10/2007)
6.	Audibert, F: 2 articles (08/2008 - 10/2007)
7.	An, N: 2 articles (08/2008 - 10/2007)
8.	Brunet, S: 2 articles (08/2008 - 10/2007)
9.	Rypens, F: 2 articles (08/2008 - 10/2007)
10.	Neri, Isabella: 2 articles (01/2007 - 05/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Pregnancy-Induced Hypertension:

1.	CalciumIBA 12/01/1999 - "OBJECTIVE: To assess the efficacy of urinary calcium and albumin output in 24 hours for prediction of the occurrence of pregnancy induced hypertension (PIH). " 12/01/1999 - "[The clinical study on urinary albumin and calcium output in 24 hours to serve as early markers for pregnancy induced hypertension]" 11/01/1995 - "OBJECTIVE: To study the predictive value of urinary calcium excretion on occurrence of pregnancy-induced hypertension (PIH). " 10/23/1992 - "The aim of the study was to evaluate the calcium metabolism in pregnancy-induced hypertension. " 04/01/1988 - "Randomized clinical trials showing a reduction in the incidence of pregnancy-induced hypertension with calcium supplementation have not as yet been published. " Order ALL the reference details at left...
2.	Dietary CalciumIBA 06/01/1995 - "OBJECTIVE: The purpose of this study is to clarify whether the taking of a calcium dietary supplement is able to prevent the development of pregnancy-induced hypertension (PIH) in Japanese people. " 06/01/1989 - "Previous studies have suggested that increased dietary calcium is associated with a decreased occurrence of pregnancy-induced hypertension. " 05/01/2000 - "Dietary calcium and pregnancy-induced hypertension: is there a relation?" 06/01/1995 - "Prevention of pregnancy-induced hypertension by calcium dietary supplement: a preliminary report." 08/01/1992 - "Epidemiologic studies have shown an inverse relationship between dietary calcium intake and gestational hypertension. " Order ALL the reference details at left...
3.	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/01/1987 - "Recent clinical studies have reported a significant reduction in the incidence of pregnancy-induced hypertension after the ingestion of low-dose aspirin. " 11/01/1995 - "We conducted a double blind prospective randomized study to investigate the effect of low dose aspirin in preventing pregnancy-induced hypertension. " 06/01/1994 - "A study of use of low dose aspirin in prevention of pregnancy induced hypertension." 11/01/1990 - "The effect of low doses of aspirin on women with mild pregnancy-induced hypertension was investigated by means of a prospective, randomized, double-blind trial. " 08/10/1989 - "We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism. " Order ALL the reference details at left...
4.	Nifedipine (Adalat)FDA LinkGeneric 03/01/2000 - "OBJECTIVE: To determine the efficacy of Nifedipine on postpartum blood Loss in patients with Pregnancy Induced Hypertension (PIH). " 11/01/1996 - "OBJECTIVES: To study the effects of nifedipine on the microcirculation in pregnancy-induced hypertension (PIH). " 01/01/2006 - "The effect of nifedipine on fetal-placental blood flow at 22-24 weeks in patients with pregnancy-induced hypertension (PIH) was evaluated. " 02/10/2003 - "METHODS: Seventeen healthy patients with singleton pregnancies and 12 non-proteinuric patients with gestational hypertension treated with nifedipine were enrolled consecutively from our University Hospital from January 2000 to January 2001. " 02/10/2003 - "OBJECTIVE: To assess the variation of body composition at term in patients with normal pregnancy and patients with gestational hypertension (GH) treated with nifedipine. " Order ALL the reference details at left...
5.	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 10/01/1993 - "The purpose of this study was to evaluate the effects of magnesium sulfate on maternal and fetal blood flow in pregnancy-induced hypertension. " 12/01/1993 - "This case report describes a patient who ingested magnesium sulfate (MgSO4) for approximately four days as a treatment for pregnancy-induced hypertension. " 10/01/1993 - "Twelve patients with pregnancy-induced hypertension were prospectively studied with transcranial pulsed Doppler and transabdominal color flow Doppler before and after infusion of a 6 gram intravenous loading dose of magnesium sulfate. " 10/01/1993 - "The effect of magnesium sulfate on maternal and fetal blood flow in pregnancy-induced hypertension." 05/01/1991 - "[Pharmacokinetic-pharmacodynamic model of magnesium sulfate in treatment of pregnancy-induced hypertension]" Order ALL the reference details at left...
6.	MagnesiumIBA 01/01/1991 - "Magnesium appeared to be beneficial in the management of pregnancy-induced hypertension. " 04/01/1987 - "Magnesium (Mg) is effective in the treatment of pregnancy-induced hypertension (PIH). " 09/01/1998 - "Because magnesium is often administered to mothers with pregnancy-induced hypertension, a condition associated with reduction in severe IVH, the independent neuroprotective role of magnesium remains unclear and warrants additional studies." 01/01/1991 - "The effects of magnesium were compared with those of placebo in a randomized double-blind controlled study of 58 patients with pregnancy-induced hypertension, of whom 27 received magnesium and 31 placebo. " 12/01/1990 - "The present study suggests that magnesium supplement has a beneficial effect on fetal growth in pregnancy-induced hypertension. " Order ALL the reference details at left...
7.	Labetalol (Normodyne)FDA LinkGeneric 01/01/1989 - "Labetalol appears to be an effective agent in the management of mild to moderate pregnancy-induced hypertension. " 12/01/1992 - "OBJECTIVE: To determine the need for, and efficacy of, treatment with labetalol in women with mild-to-moderate pregnancy induced hypertension (PIH). " 12/01/1992 - "CONCLUSION: Anti-hypertensive intervention therapy in pregnancy induced hypertension has been examined using a placebo controlled randomised double-blind trial of labetalol in pregnancy. " 12/01/1992 - "A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension." 01/01/1989 - "The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension." Order ALL the reference details at left...
8.	Antihypertensive Agents (Antihypertensives)IBA 01/01/1990 - "A better understanding of the hemodynamic abnormalities in gestational hypertension together with the use of effective antihypertensive agents have resulted in more rational therapeutic approaches and a substantial improvement in maternal and fetal welfare. " 03/15/1990 - "Antihypertensive drugs could be administered to prolong pregnancy when this is considered desirable, although pharmacological therapy of gestational hypertension remains a subject for dispute, because of the lack of closely controlled studies. " 05/08/1982 - "No study has yet afforded evidence that the use of anti-hypertensive drugs in gestational hypertension benefits the foetus. " 03/01/2000 - "Review: antihypertensive drugs improve maternal outcomes in mild chronic and pregnancy-induced hypertension." 01/09/1998 - "Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states." Order ALL the reference details at left...
9.	Dinoprostone (PGE2)FDA Link 11/01/1987 - "Postdatism, pregnancy-induced hypertension and rupture of the membranes were the major indications for induction of labor, accounting for 70% of the PGE2 group and 88% of the OA group. " 01/01/1995 - "Statistically significant differences were found between the study and the control groups regarding the incidence of instrumental (forceps/vacuum) deliveries, prolonged second stage, pregnancy-induced hypertension, prostaglandin E2 induction, premature rupture of membranes and episiotomy. " 11/01/1989 - "[Prostaglandin E2, F2 alpha,6-keto-prostaglandin F1 alpha and thromboxane B2 in the placenta of normotensive women and women with pregnancy induced hypertension]" 01/15/1980 - "Effect of pregnancy-induced hypertension upon placental prostaglandin metabolism: decreased prostaglandin F2alpha catabolism with normal prostaglandin E2 catabolism." 07/01/1993 - "It is suggested that a single insertion of PGE2 vaginal tablet is effective for induction of labour in the multiparae in cases of Pregnancy Induced Hypertension (PIH), Post-maturity; and intra-uterine fetal death (IUD) but similar procedure may not be so effective in the primiparae." Order ALL the reference details at left...
10.	Linoleic Acid (Linoleate)IBA 08/01/2001 - "RESULTS: Calcium linoleic acid and mono and polyunsaturated fatty acid supplements were effective in significantly reducing the incidence of gestational hypertension (p>0.05); in fact 90% of patients in Group A underwent a physiological evolution of pregnancy compared to only 10% affected by gestational hypertension. " 08/01/2001 - "CONCLUSIONS: The authors conclude that calcium linoleic acid and mono and polyunsaturated fatty acid supplements are useful and effective in the prevention of gestational hypertension in women at risk for this pathology." 04/01/2006 - "Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes." 12/01/2005 - "OBJECTIVE: To determine the effect of dietary supplementation of calcium plus conjugated linoleic acid (calcium-CLA) in reducing the incidence of vascular endothelial dysfunction in pregnant women at high risk of developing pregnancy-induced hypertension (PIH). " 12/01/2005 - "Calcium plus linoleic acid therapy for pregnancy-induced hypertension." Order ALL the reference details at left...

Therapies and Procedures

1.	Cesarean Section (Caesarean Section) 01/01/1992 - "The study group consisted of 58 women with a pregnancy-induced hypertension or an otherwise presumed uteroplacental perfusion impairment delivered by cesarean section. " 05/01/2006 - "Many obese women conceive without assistance, but pregnancies in obese women have increased rates of pregnancy-associated hypertension, gestational diabetes, large babies, Cesarean section and perinatal mortality and morbidity. " 02/01/2006 - "Women with GDM also had a higher risk of Caesarean section (P 0.05), gestational hypertension (P 0.05), and large for gestational age (LGA) deliveries (P 0.005). " 09/01/2005 - "The upper quartile of BMI accounted for 23% of macrosomia, 9.4% of Caesarean section, 50% of pregnancy-induced hypertension and 17.6% of large-for-gestational-age newborns. " 06/01/2005 - "Were mainly investigated: glycemic control (HbA1C), fetal outcome (congenital malformations, preterm delivery, perinatal mortality), rates of gestational hypertension and cesarean section. " Order ALL the reference details at left...
2.	Epidural Anesthesia 06/15/1985 - "These results demonstrate that continuous lumbar epidural anesthesia is safe and effective for both the fetus and the mother with pregnancy-induced hypertension." 06/15/1985 - "The use of continuous lumbar epidural anesthesia in women with pregnancy-induced hypertension remains controversial. " 01/01/2003 - "While limiting the fetal exposure to the harmful effects of depressant drugs, epidural anesthesia and/or analgesia improves placental perfusion and oxygenation of the fetus, which is beneficial, especially in conditions such as pregnancy-induced hypertension. " 03/01/2005 - "Cases and control subjects were chosen randomly and patients' records were reviewed for the following variables: maternal age, parity, gestational age, tobacco use, gestational diabetes or pregnancy-induced hypertension, use of peridural anesthesia, duration of first and second stages of labor, use of mediolateral episiotomy, forceps combined with mediolateral episiotomy, induction of labor, infant head diameter, shoulder circumference, and birth weight. " 01/01/1990 - "We found that a high bilirubin level was significantly associated with male sex; maternal diabetes (chronic and gestational); pregnancy-induced hypertension; previous sibling with neonatal jaundice; delivery by cesarean section, vacuum, or forceps; epidural anesthesia; mother with blood type O; first delivery; cephalohematoma; short gestation; lower birth weight; and lower birth order (p less than 0.01); and older maternal age, low percentile for birth weight, and the percentage of weight loss during hospitalization (p less than 0.05). " Order ALL the reference details at left...
3.	Cardiopulmonary Resuscitation (CPR) 08/01/1994 - "Conclusion: this investigation demonstrates that in pregnancy-induced hypertension (even with moderate growth retardation, and no neonatal complication), the diagnostic efficacy of CPR for predicting SGA at birth is very high and that of renal RI correlates very poorly with fetal growth." Order ALL the reference details at left...
4.	Intrauterine Devices (Intrauterine Device) 07/01/1993 - "The indications for induction of labour were Pregnancy Induced Hypertension (PIH); Post-maturity, Intra-uterine foetal death IUD, spontaneous rupture of membrane, diabetes mellitus in pregnancy and intra uterine growth retardation syndrome (IUGR). " 07/01/1993 - "It is suggested that a single insertion of PGE2 vaginal tablet is effective for induction of labour in the multiparae in cases of Pregnancy Induced Hypertension (PIH), Post-maturity; and intra-uterine fetal death (IUD) but similar procedure may not be so effective in the primiparae." Order ALL the reference details at left...
5.	Analgesia 10/01/2001 - "OBJECTIVE: The purpose of this study was to compare the peripartum and perinatal effects of epidural with intravenous labor analgesia in women with pregnancy-induced hypertension. " 09/01/2005 - "Labor analgesia for the parturient with pregnancy-induced hypertension: what does an obstetrician need to know?" 10/01/2001 - "A randomized trial of labor analgesia in women with pregnancy-induced hypertension." 01/01/2004 - "METHODS: Between November 1, 1993, and November 3, 2000, 2,703 nulliparous women (2,188 healthy parturients and 515 women with pregnancy-induced hypertension) in spontaneous labor at term were randomized to receive either epidural analgesia or intravenous opioid analgesia in the five studies. " 01/01/2003 - "While limiting the fetal exposure to the harmful effects of depressant drugs, epidural anesthesia and/or analgesia improves placental perfusion and oxygenation of the fetus, which is beneficial, especially in conditions such as pregnancy-induced hypertension. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Pregnancy-Induced Hypertension

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 36 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>